Stock Events

Galmed Pharmaceuticals (GLMD) Q4 2022 Earnings

29MarConfirmed
Aug 22
Nov 22
Jan 23
Q4 2022
-0.24
-0.19
-0.15
-0.1

Details

Expected EPS
-0.14
Actual EPS
-0.1
Surprise EPS
0.04
Surprise Percent
+28.57%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.1 per share for Q4 2022.

0 Comments

Share your thoughts